688321.SHG Shenzhen Chipscreen Biosciences Co

Healthcare Pharmaceuticals Shanghai Stock Exchange
21.19 CNY
Close of Nov 5, 2026
19.41 36.47
Market cap
CNY 9.39B
P/E
124.6x
P/B
3.43x
ROE
4.8%
Dividend yield
0.34%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688321.SHG undervalued?

Graham number

The Graham number of Shenzhen Chipscreen Biosciences Co cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shenzhen Chipscreen Biosciences Co fundamental analysis

No fundamental analysis for Shenzhen Chipscreen Biosciences Co yet.

Shenzhen Chipscreen Biosciences Co stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shenzhen Chipscreen Biosciences Co

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the pharmaceutical industry in China. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for peripheral T-cell lymphoma, breast cancer, and diffuse large B-cell lymphoma indications; Chiglitazar, a PPAR full agonist for diabetes treatment; Siglitazone for metabolism treatment area; and Cioronib, a novel molecular, which selectively inhibits tumor-related protein kinase targets. It is also inv…

Full company profile